Phase 3 Maintenance Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

Maintenance Treatment of Peripheral T-cell Lymphoma

Fudan University136 enrolled1 locationNCT07300514

Recruiting

Phase 3

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

Acute Myeloid Leukemia (AML)Maintenance TherapyAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more

The First Affiliated Hospital of Soochow University594 enrolled2 locationsNCT07463651

Recruiting

Phase 3

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal CarcinomaHigh-Risk CancerMaintenance Therapy

Jiangxi Provincial Cancer Hospital264 enrolled3 locationsNCT06277050